Disclosure Of Entity's Operating Segments [Text Block]

Affluent Medical - Filing #858612

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
- EUR
- EUR
Depreciation and amortisation expense
2 450 EUR
2 420 EUR
Share of profit (loss) of associates and joint ventures accounted for using equity method
- EUR
14,000 EUR
Tax expense (income)
173,000 EUR
437,000 EUR
Profit (loss) before tax
15 400 EUR
15 257 EUR
Profit (loss)
- EUR
15 227 EUR
15 227 EUR
- EUR
- EUR
- EUR
15 227 EUR
- EUR
- EUR
14 820 EUR
- EUR
- EUR
- EUR
- EUR
14 820 EUR
14 820 EUR
Assets
60 020 EUR
70 035 EUR
Investments accounted for using equity method
- EUR
- EUR
Cash flows from (used in) operating activities
11 081 EUR
12 364 EUR
Cash flows from (used in) investing activities
146,000 EUR
160,000 EUR
Cash flows from (used in) financing activities
2 401 EUR
18 281 EUR
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.